Clinical Trial News and Research

RSS

Decitabine improves myelodysplastic syndrome treatment

A potent member of a new class of drugs increases survival in some patients with myelodysplastic syndrome (MDS), and may become the new standard of therapy for this group of pre-cancer disorders

14 Mar 2006

Using a growth factor to stimulate production of circulating endothelial progenitor cells improves cell production and mobility in arterial disease

Using a growth factor to stimulate production of circulating endothelial progenitor cells increases the numbers of these vascular regenerative cells, improves mobility, and potentially could improve blood vessel function in patients with peripheral arterial disease (PAD).

13 Mar 2006

Trial explores safety and efficacy of injecting human stem cells directly into the brain to treat fatal pediatric neurodegenerative disorder

Researchers in Doernbecher Children's Hospital at Oregon Health & Science University will begin a Phase I clinical trial using stem cells in infants and children with a rare neurodegenerative disorder that affects infants and children.

13 Mar 2006

Yale School of Medicine expands research using transcranial magnetic stimulation for schizophrenia

Yale School of Medicine researchers are recruiting patients nationally for a clinical trial using transcranial magnetic stimulation (TMS) to help still the voices that are so troubling to some persons with schizophrenia.

9 Mar 2006

Expressing anger in the moment is not healthy

According to a new book, Getting Control of Your Anger: A Clinically Proven, Three-Step Plan for Getting to the Root of the Problem and Resolving It (McGraw-Hill, 2006) by Dr. Robert Allan, a noted clinical psychologist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, for most people and in most circumstances, directly expressed anger will only make a bad situation worse.

9 Mar 2006

Repligen commences phase 2 trial of RG2417 for bipolar depression

Repligen Corporation today announced that the Company has initiated a Phase 2 clinical trial of RG2417, an oral formulation of uridine, in patients with bipolar depression.

9 Mar 2006

Lilly launches phase III trial of Enzastaurin

One of the deadliest and rarest forms of cancer is the focus of a Phase III study initiated by Eli Lilly and Company today.

9 Mar 2006

Study supports guidelines for treatment of aortic regurgitation

Patients with leaky aortic heart valves appear to do better when the valves are replaced before significant symptoms develop, as recommended by the American College of Cardiology/American Heart Association guidelines, according to a new study in the Journal of the American College of Cardiology.

9 Mar 2006

Revatio now available in the UK

Patients in the UK suffering from a rare life-threatening heart condition, pulmonary arterial hypertension (PAH), could soon be offered a new treatment.

8 Mar 2006

Will the FDA rise to the occasion and admit their natalizumab mistake?

When Anita Louise Smith enrolled in an experimental drug trial in 2002 in Colorado, she had a diagnosis of multiple sclerosis but no symptoms and was looking to reduce the chances of being ravaged by the disease.

7 Mar 2006

Data from Novogen inflammatory bowel disease drug Phase I clinical trial shows promise

A recently completed Phase 1 clinical trial of an investigational drug to treat inflammatory bowel disease has demonstrated rapid absorption indicating potential for development as an oral therapy.

6 Mar 2006

UCB submits application to FDA for new treatment in Crohn's disease

UCB has announced the submission of a Biologics License Application (BLA) to the United States Food and Drug Administration (FDA) for the approval of CIMZIA (certolizumab pegol, CDP870) for the treatment of patients with Crohn's disease.

6 Mar 2006

FDA gives greenlight for new treatment of head and neck cancer

The U.S. Food and Drug Administration has approved colon cancer drug Erbitux to treat head and neck cancer after results of a large clinical trial showed the drug prolonged survival by 20 months.

5 Mar 2006

Clinical trial of new Bionovo menopause drug moves forward

Today, millions of women suffer from often-harsh symptoms of menopause such as hot flashes and night sweats -- and relief is nowhere to be found.

27 Feb 2006

Xenon gas shown to be safe in surgery and could help stop nervedamaging illnesses

Scientists have successfully conducted the first clinical trial giving xenon gas to patients undergoing coronary artery bypass grafting in order to safeguard against postoperative brain damage that can occur following this procedure.

27 Feb 2006

Viagra could cure Crohn's disease

Crohn's disease is a chronic inflammatory bowel disorder which causes ulcerations in the gut and can make digesting food painful.

27 Feb 2006

Combination of glucosamine and chondroitin sulfate may be effective in some patients with moderate-to-severe knee pain

Offering hope for millions of people who suffer the most from osteoarthritis, a study published in the New England Journal of Medicine (NEJM) has found that the combined use of two dietary supplements - glucosamine and chondroitin - provided significant pain relief from the most common form of arthritis.

24 Feb 2006